Bortezomib appears to overcome the poor prognosis conferred by chromosome 13 deletion in phase 2 and 3 trials (Q79345406)
scientific article published on 09 November 2006
Language:
(P31) (Q13442814)
(P50) (Q85544110)
(P304) 151-157
(P433) 1
(P478) 21
(P577) Thursday, November 9, 2006
(P921) (Q42824440)
(P1433) (Q6534498)
(P1476) "Bortezomib appears to overcome the poor prognosis conferred by chromosome 13 deletion in phase 2 and 3 trials" (language: en)
(P2093) Jagannath S
Richardson PG
Sonneveld P
Schuster MW
Irwin D
Facon T
Harousseau JL
Cowan JM
Anderson KC
(P2860) (Q57905100)
(Q73586012)
(Q44950046)
(Q73494830)
(Q76381510)
(Q35848356)
(Q35883816)
(Q44256350)
(Q34435590)
(Q33348702)
(Q33363081)
(Q46549268)
(Q34408882)
(Q36254607)
(Q74346534)
(Q73832116)
(Q58050935)
(Q79739589)
(Q45310359)
(Q44507288)
(Q60203808)
(Q46981475)
(Q78799149)
(Q76376753)
(Q46937913)
other details
description scientific article published on 09 November 2006

External Links